Hoey Investments’s AIM ImmunoTech AIM Stock Holding History

Hoey Investments’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Hold	10	–	–	﹤0.01%	456
2026 Q1	$6	Hold	10	–	–	﹤0.01%	418
2025 Q4	$12	Hold	10	–	–	﹤0.01%	421
2025 Q3	$28	Hold	10	–	–	﹤0.01%	407
2025 Q2	$87	Hold	10	–	–	﹤0.01%	400
2025 Q1	$123	Hold	10	–	–	﹤0.01%	359
2024 Q4	$198	Hold	10	–	–	﹤0.01%	347
2024 Q3	$373	Hold	10	–	–	﹤0.01%	364
2024 Q2	$373	Hold	10	–	–	﹤0.01%	364
2024 Q1	$471	Hold	10	–	–	﹤0.01%	327
2023 Q4	$440	Hold	10	–	–	﹤0.01%	330
2023 Q3	$455	Hold	10	–	–	﹤0.01%	332
2023 Q2	$670	Hold	10	–	–	﹤0.01%	325
2023 Q1	$430	Hold	10	–	–	﹤0.01%	336
2022 Q4	$312	Hold	10	–	–	﹤0.01%	288
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	306
2022 Q2	$1K	Hold	10	–	–	﹤0.01%	278
2022 Q1	$1K	Hold	10	–	–	﹤0.01%	246
2021 Q4	$1K	Buy	+10	New	+$1.55K	﹤0.01%	237

Other funds holding AIM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GSC

Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Hoey Investments's AIM Position: Q2 2026 in Review

Hoey Investments held its AIM ImmunoTech (AIM) position steady in Q2 2026 at 10 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #456.

Hoey Investments first reported a position in AIM in Q4 2021 and has held it in 19 quarters since. The position peaked at $1K in Q3 2022. 18 funds tracked by Wall St. Rank hold AIM as of Q2 2026.

Hoey Investments held 10 shares of AIM ImmunoTech worth $3 as of Q2 2026.
Hoey Investments left its AIM ImmunoTech share count unchanged in Q2 2026.
AIM ImmunoTech made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #456 holding.
Hoey Investments first reported a position in AIM ImmunoTech in Q4 2021 and has held it in 19 quarters since.
Hoey Investments's AIM ImmunoTech position peaked at $1K in Q3 2022.
18 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.